151 related articles for article (PubMed ID: 30215205)
1. Epigenetic markers in basal cell carcinoma: universal themes in oncogenesis and tumor stratification? - a short report.
Rao RC; Chan MP; Andrews CA; Kahana A
Cell Oncol (Dordr); 2018 Dec; 41(6):693-698. PubMed ID: 30215205
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations in sporadic basal cell carcinomas.
Stamatelli A; Vlachou C; Aroni K; Papassideri I; Patsouris E; Saetta AA
Arch Dermatol Res; 2014 Aug; 306(6):561-9. PubMed ID: 24573469
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modifications in cutaneous malignant melanoma: EZH2, H3K4me2, and H3K27me3 immunohistochemical expression is enhanced at the invasion front of the tumor.
Kampilafkos P; Melachrinou M; Kefalopoulou Z; Lakoumentas J; Sotiropoulou-Bonikou G
Am J Dermatopathol; 2015 Feb; 37(2):138-44. PubMed ID: 25614949
[TBL] [Abstract][Full Text] [Related]
6. The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.
Ngollo M; Lebert A; Dagdemir A; Judes G; Karsli-Ceppioglu S; Daures M; Kemeny JL; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
BMC Cancer; 2014 Dec; 14():994. PubMed ID: 25535400
[TBL] [Abstract][Full Text] [Related]
7. Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin.
Omland SH; Wettergren EE; Mollerup S; Asplund M; Mourier T; Hansen AJ; Gniadecki R
BMC Cancer; 2017 Oct; 17(1):675. PubMed ID: 28987144
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinomas of the scalp after radiotherapy for tinea capitis in childhood: A genetic and epigenetic study with comparison with basal cell carcinomas evolving in chronically sun-exposed areas.
Cardoso JC; Ribeiro IP; Caramelo F; Tellechea O; Barbosa de Melo J; Marques Carreira I
Exp Dermatol; 2021 Aug; 30(8):1126-1134. PubMed ID: 33205471
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of Biopsy in Subtyping Periocular Basal Cell Carcinoma.
Sun MT; Wu A; Huilgol SC; Selva D
Ophthalmic Plast Reconstr Surg; 2015; 31(6):449-51. PubMed ID: 25794023
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics and cutaneous neoplasms: from mechanism to therapy.
Gibson F; Hanly A; Fisher R; Wyant WA; Wu M; Collard M; Alani RM
Epigenomics; 2023 Feb; 15(3):167-187. PubMed ID: 37020393
[TBL] [Abstract][Full Text] [Related]
11. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
13. Molecular signatures linked with aggressive behavior in basal cell carcinoma: a report of 6 cases.
Fernandes H; Fernandes N; Bhattacharya S; Chen W; Seth A; Hameed M; Mirani N; Lambert WC
Am J Dermatopathol; 2010 Aug; 32(6):550-6. PubMed ID: 20489570
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Alterations in Keratinocyte Carcinoma.
Yao Q; Epstein CB; Banskota S; Issner R; Kim Y; Bernstein BE; Pinello L; Asgari MM
J Invest Dermatol; 2021 May; 141(5):1207-1218. PubMed ID: 33212152
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
Bartoš V; Kullová M
Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
[TBL] [Abstract][Full Text] [Related]
16. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
[TBL] [Abstract][Full Text] [Related]
17. Nonrandom karyotypic features in basal cell carcinomas of the skin.
Jin Y; Martins C; Salemark L; Persson B; Jin C; Miranda J; Fonseca I; Jonsson N
Cancer Genet Cytogenet; 2001 Dec; 131(2):109-19. PubMed ID: 11750050
[TBL] [Abstract][Full Text] [Related]
18. Basal cell carcinoma: a dermatopathological and molecular biological update.
Saldanha G; Fletcher A; Slater DN
Br J Dermatol; 2003 Feb; 148(2):195-202. PubMed ID: 12588368
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53 in arsenic-related and sporadic basal cell carcinoma.
Boonchai W; Walsh M; Cummings M; Chenevix-Trench G
Arch Dermatol; 2000 Feb; 136(2):195-8. PubMed ID: 10677095
[TBL] [Abstract][Full Text] [Related]
20. Molecular Variations in Histologic Subtypes of Basal Cell Carcinoma.
Deng M; Marsch AF; Petronic-Rosic V
Skinmed; 2017; 15(4):265-268. PubMed ID: 28859735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
